NADH-CoQ REDUCTASE DEFICIENT MYOPATHY: SUCCESSFUL TREATMENT WITH RIBOFLAVIN

W.F.M. Arts(Rotterdam University of Applied Sciences), H.R. Scholte(Rotterdam University of Applied Sciences), J. M. Bogaard(Rotterdam University of Applied Sciences), K. F. Kerrebijn(Rotterdam University of Applied Sciences), I. E. M. Luyt‐Houwen(Rotterdam University of Applied Sciences)

The Lancet

September 1, 1983

10.1016/s0140-6736(83)90618-9

Cited by 439

Abstract

Related Papers

Textbook of Work Physiology

Per‐Olof Åstrand, Kåre Rodahl|Unknown|1970|4.5k

LONG-TERM FOLLOW-UP OF PATIENTS WHO RECEIVED 10,098 SPINAL ANESTHETICS

Leroy D. Vandam|Journal of the American Medical Association|1956|383

Neural Blockade in Clinical Anesthesia and Management of Pain

&NA;|Anesthesia & Analgesia|1981|342

Salmonellosis — A Review of Some Unusual Aspects

Paul H. Black, Lawrence J. Kunz, Morton N. Swartz|New England Journal of Medicine|1960|257

C6—C10-Dicarboxylic Aciduria: Investigations of a Patient with Riboflavin Responsive Multiple Acyl-CoA Dehydrogenation Defects

N. Gregersen, H Wintzensen, Steen-Erik Christensen et al.|Pediatric Research|1982|119